FLT3 and acute myeloid leukemia: While the clinical significance of FLT3-TKD in AML has still remained controversial, it has been well established that FLT3-ITD confers a poor prognosis mostly due to higher relapse rates leading to inferior disease-free and overall survivals, which is particularly significant in AML with higher mutant to wild-type allelic ratio [3, 4].